(a) attracting greater investor interest - the Consolidation will have the immediate effect of effecting the share price by the consolidation ratio. It is the Company's belief that the Consolidation ...
Caris Life Sciences, Inc. is rated a Hold with positive EBITDA & free cash flow driven by strong MI segment performance. Read ...
Greenridge Capital has initiated coverage on Cango Inc. ("Cango" or the "Company") with a buy rating and US$4.00 target price, noting that Cango appears to be "mispriced and overlooked by the market ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback